These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 19273471

  • 1. Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone.
    Yip PP, Woo CF, Tang HH, Ho CK.
    Br J Ophthalmol; 2009 Jun; 93(6):754-8. PubMed ID: 19273471
    [Abstract] [Full Text] [Related]

  • 2. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.
    Ahmadieh H, Taei R, Soheilian M, Riazi-Esfahani M, Karkhaneh R, Lashay A, Azarmina M, Dehghan MH, Moradian S.
    BMC Ophthalmol; 2007 Jun 07; 7():10. PubMed ID: 17555600
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).
    Costa RA, Jorge R, Calucci D, Melo LA, Cardillo JA, Scott IU.
    Graefes Arch Clin Exp Ophthalmol; 2007 Sep 07; 245(9):1273-80. PubMed ID: 17333238
    [Abstract] [Full Text] [Related]

  • 4. Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.
    Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, Schmidt-Erfurth U.
    Br J Ophthalmol; 2008 Mar 07; 92(3):356-60. PubMed ID: 18303156
    [Abstract] [Full Text] [Related]

  • 5. Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration.
    el Matri L, Chebil A, Kort F, Bouraoui R, Baklouti K, Mghaieth F.
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun 07; 248(6):779-84. PubMed ID: 20169357
    [Abstract] [Full Text] [Related]

  • 6. Single-session photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.
    Ahmadieh H, Taei R, Soheilian M, Riazi-Esfahani M, Ahadi H.
    Eur J Ophthalmol; 2008 Jun 07; 18(2):297-300. PubMed ID: 18320527
    [Abstract] [Full Text] [Related]

  • 7. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.
    Chan WM, Lai TY, Wong AL, Tong JP, Liu DT, Lam DS.
    Br J Ophthalmol; 2006 Mar 07; 90(3):337-41. PubMed ID: 16488958
    [Abstract] [Full Text] [Related]

  • 8. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.
    Dhalla MS, Shah GK, Blinder KJ, Ryan EH, Mittra RA, Tewari A.
    Retina; 2006 Mar 07; 26(9):988-93. PubMed ID: 17151484
    [Abstract] [Full Text] [Related]

  • 9. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ, Schmidt-Erfurth U.
    Ophthalmology; 2006 Jan 07; 113(1):14-22. PubMed ID: 16360209
    [Abstract] [Full Text] [Related]

  • 10. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
    Smith BT, Dhalla MS, Shah GK, Blinder KJ, Ryan EH, Mittra RA.
    Retina; 2008 May 07; 28(5):675-81. PubMed ID: 18463509
    [Abstract] [Full Text] [Related]

  • 11. Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.
    Introini U, Torres Gimeno A, Scotti F, Setaccioli M, Giatsidis S, Bandello F.
    Graefes Arch Clin Exp Ophthalmol; 2012 Sep 07; 250(9):1283-92. PubMed ID: 22350060
    [Abstract] [Full Text] [Related]

  • 12. Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.
    Kaiser PK, Registry of Visudyne AMD Therapy Writing Committee, Boyer DS, Garcia R, Hao Y, Hughes MS, Jabbour NM, Kaiser PK, Mieler W, Slakter JS, Samuel M, Tolentino MJ, Roth D, Sheidow T, Strong HA.
    Ophthalmology; 2009 Apr 07; 116(4):747-55, 755.e1. PubMed ID: 19243834
    [Abstract] [Full Text] [Related]

  • 13. Intravitreal bevacizumab for exudative age-related macular degeneration after multiple treatments.
    Aggio FB, Farah ME, Silva WC, Melo GB.
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb 07; 245(2):215-20. PubMed ID: 17139490
    [Abstract] [Full Text] [Related]

  • 14. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF, Sorenson J, Maranan L.
    Ophthalmology; 2003 Aug 07; 110(8):1517-25. PubMed ID: 12917166
    [Abstract] [Full Text] [Related]

  • 15. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
    Lazic R, Gabric N.
    Ophthalmology; 2007 Jun 07; 114(6):1179-85. PubMed ID: 17544776
    [Abstract] [Full Text] [Related]

  • 16. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
    Ladas ID, Kotsolis AI, Papakostas TD, Rouvas AA, Karagiannis DA, Vergados I.
    Retina; 2007 Sep 07; 27(7):891-6. PubMed ID: 17891013
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
    Bidot ML, Malvitte L, Bidot S, Bron A, Creuzot-Garcher C.
    J Fr Ophtalmol; 2011 Jun 07; 34(6):376-81. PubMed ID: 21550687
    [Abstract] [Full Text] [Related]

  • 18. Combined intravitreal bevacizumab and photodynamic therapy for neovascular age-related macular degeneration.
    Ladewig MS, Karl SE, Hamelmann V, Helb HM, Scholl HP, Holz FG, Eter N.
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan 07; 246(1):17-25. PubMed ID: 17701197
    [Abstract] [Full Text] [Related]

  • 19. Triple therapy for neovascular age-related macular degeneration (verteporfin photodynamic therapy, intravitreal dexamethasone, and intravitreal bevacizumab).
    Ehmann D, García R.
    Can J Ophthalmol; 2010 Feb 07; 45(1):36-40. PubMed ID: 20130708
    [Abstract] [Full Text] [Related]

  • 20. Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response.
    Schadlu R, Kymes SM, Apte RS.
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov 07; 245(11):1667-72. PubMed ID: 17583819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.